Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Wegovy maker Novo Nordisk is moving its investigational amycretin asset into late-stage weight loss trials starting early ...

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.

It’s the hot-shot fix that took Hollywood — and now high school — by storm. Ozempic and other so-called “miracle” weight-loss ...

Patients may eventually access weight-loss jabs at pharmacies in a drive to ‘turn the tide’ on rising obesity, Professor Sir ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

WEIGHT loss jabs could one day be dished out like statins, England’s top doctor says. Professor Sir Stephen Powis, medical ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Novo Nordisk, the maker of Ozempic and Wegovy weight-loss drugs, just regained the title as Europe’s most valuable company ...